EBV Lytic Reactivation Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EBV Lytic Reactivation Therapy, covering 2025-08-24 to 2025-08-24. Get the full timeline:
Most recent: Clinical Trial Update: EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]